The Valley Desk

NCT01179217 · Interventional trial

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Overall registry status Completed

Phase 3

Conditions Sickle Cell Anemia, Sickle ß0-Thalassemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov